- Home
- MRSN vs WTBA Comparison
MRSN vs WTBA Comparison
Compare MRSN & WTBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- WTBA
- Stock Information
- Founded
- MRSN 2001
- WTBA 1893
- Country
- MRSN United States
- WTBA United States
- Employees
- MRSN N/A
- WTBA N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- WTBA Major Banks
- Sector
- MRSN Health Care
- WTBA Finance
- Exchange
- MRSN Nasdaq
- WTBA Nasdaq
- Market Cap
- MRSN 252.0M
- WTBA 301.1M
- IPO Year
- MRSN 2017
- WTBA N/A
- Fundamental
- Price
- MRSN $0.62
- WTBA $21.34
- Analyst Decision
- MRSN Buy
- WTBA Hold
- Analyst Count
- MRSN 6
- WTBA 1
- Target Price
- MRSN $6.00
- WTBA $23.00
- AVG Volume (30 Days)
- MRSN 7.3M
- WTBA 28.3K
- Earning Date
- MRSN 02-26-2025
- WTBA 01-23-2025
- Dividend Yield
- MRSN N/A
- WTBA 4.69%
- EPS Growth
- MRSN N/A
- WTBA N/A
- EPS
- MRSN N/A
- WTBA 1.27
- Revenue
- MRSN $34,837,000.00
- WTBA $77,394,000.00
- Revenue This Year
- MRSN N/A
- WTBA N/A
- Revenue Next Year
- MRSN N/A
- WTBA $13.99
- P/E Ratio
- MRSN N/A
- WTBA $16.80
- Revenue Growth
- MRSN N/A
- WTBA N/A
- 52 Week Low
- MRSN $0.56
- WTBA $15.80
- 52 Week High
- MRSN $6.28
- WTBA $24.85
- Technical
- Relative Strength Index (RSI)
- MRSN 20.37
- WTBA 45.51
- Support Level
- MRSN $0.56
- WTBA $20.90
- Resistance Level
- MRSN $1.45
- WTBA $21.58
- Average True Range (ATR)
- MRSN 0.14
- WTBA 0.65
- MACD
- MRSN -0.06
- WTBA 0.03
- Stochastic Oscillator
- MRSN 6.49
- WTBA 74.43
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.
About WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.